GHRP-6 5 mg + CJC-1295 2 mg – Oxy Peptide

Oxy Peptide GHRP-6 5 mg + CJC-1295 2 mg is a premium dual-peptide research formulation combining Growth Hormone Releasing Peptide-6 (GHRP-6) with CJC-1295, a Growth Hormone Releasing Hormone (GHRH) analogue. This advanced peptide blend is extensively studied for its complementary interaction with growth hormone signaling pathways, providing researchers with a valuable platform for investigating endocrine physiology, peptide synergy, receptor activation, and hormone-mediated cellular communication.

Presented in a lyophilized 7 mg vial, this high-purity research formulation is manufactured to ensure exceptional stability, consistency, and reliability for advanced laboratory applications. By combining a well-established growth hormone secretagogue with a GHRH analogue, Oxy Peptide GHRP-6 + CJC-1295 enables researchers to explore peptide pharmacology, growth hormone physiology, metabolic biology, and cellular signaling mechanisms under controlled scientific conditions.

Manufactured under stringent quality standards, Oxy Peptide GHRP-6 + CJC-1295 is intended exclusively for laboratory and scientific research, delivering the precision and purity expected by professionals engaged in modern peptide science.

Key Features

• Advanced dual-peptide research blend
• Combines GHRP-6 and CJC-1295 in one formulation
• Total peptide content: 7 mg per vial
• 1 lyophilized vial per pack
• High-purity research-grade formulation
• Commonly studied in growth hormone and endocrine pathway research
• Suitable for investigations involving peptide synergy, receptor signaling, hormone regulation, and cellular communication
• Manufactured under strict quality standards
• Intended exclusively for laboratory and scientific research applications

Contents

Active Ingredients:

• Growth Hormone Releasing Peptide-6 (GHRP-6) – 5 mg
• CJC-1295 – 2 mg

Packaging: 1 Lyophilized Vial